Cardiff Oncology Inc.

NASDAQ: CRDF · Real-Time Price · USD
2.30
-0.13 (-5.35%)
At close: Aug 19, 2025, 3:59 PM
2.30
0.00%
After-hours: Aug 19, 2025, 04:31 PM EDT

Cardiff Oncology Revenue

Cardiff Oncology reported an annual revenue of $683K, reflecting a 39.96% growth. For the quarter ending June 30, 2025, Cardiff Oncology generated $0 in revenue.
Revenue (ttm)
683K
Revenue Growth
39.96%
Price / Sales Ratio
302.78
Revenue / Employee
21.34K
Employees
32
Market Cap
153.01M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 683K +39.96%
Dec 31, 2023 488K +26.42%
Dec 31, 2022 386K +7.52%
Dec 31, 2021 359K -1.91%
Dec 31, 2020 365.99K +49.38%
Dec 31, 2019 245K -35.19%
Dec 31, 2018 378K -25.15%
Dec 31, 2017 505K +32.55%
Dec 31, 2016 381K +21.73%
Dec 31, 2015 313K +11.79%
Dec 31, 2014 280K +8.01%
Dec 31, 2013 259.25K -42.39%
Dec 31, 2012 450K +74.62%
Dec 31, 2011 257.7K -3.00%
Dec 31, 2010 265.67K -59.13%
Dec 31, 2009 650K +Infinity%
Jan 31, 2006 0 n/a
Jan 31, 2005 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.